Harnessing clonal evolution in chronic lymphocytic leukemia

Project Information

CLLCLONE

Grant agreement ID: 772051

DOI 10.3030/772051

Project closed

EC signature date 7 February 2018

Start date 1 July 2018

End date 30 June 2023

Funded under

• EXCELLENT SCIENCE - European Research Council (ERC)

Total cost € 1 940 000,00

EU contribution € 1 940 000,00

Coordinated by

FONDAZIONE PER L'ISTITUTO ONCOLOGICO DI RICERCA (IOR)
Switzerland

Publications

Peer reviewed articles (9)

International prognostic score for asymptomatic early-stage chronic lymphocytic leukemia

Author(s): Adalgisa Condoluci, Lodovico Terzi di Bergamo, Petra Langerbeins, Manuela A. Hoechstetter, Carmen D. Herling, Lorenzo De Paoli, Julio Delgado, Kari G. Rabe, Massimo Gentile, Michael Doubek, Francesca R. Mauro, Giorgia Chiodin, Mattias Mattsson, Jasmin Bahlo, Giovanna Cutrona, Jana Kotaskova, Clara Deambrogi, Karin E. Smedby, Valeria Spina, Alessio Bruscaggin, Wei Wu, Riccardo Moia, Elena Bianchi,
Published in: Blood, Issue 135/21, 2020, Page(s) 1859-1869, ISSN 0006-4971
Publisher: American Society of Hematology
DOI: 10.1182/blood.2019003453

Higher-order connections between stereotyped subsets: implications for improved patient classification in CLL

Author(s): Andreas Agathangelidis, Anastasia Chatzidimitriou, Katerina Gemenetzi, Veronique Giudicelli, Maria Karypidou, Karla Plevova, Zadie A Davis, Xiao-Jie Yan, Sabine Jeromin, Christof Schneider, Lone Bredo Pedersen, Renee Tschumper, Lesley A Sutton, Panagiotis Baliakas, Lydia Scarfò, Ellen J. van Gastel, Marine Armand, Eugen Tausch, Bella Biderman, Constance Baer, Davide Bagnara, Alba Navarro, Anne de
Published in: Blood, 2020, ISSN 0006-4971
Publisher: American Society of Hematology
DOI: 10.1182/blood.2020007039

Biological and clinical implications of BIRC3 mutations in chronic lymphocytic leukemia

Author(s): Fary Diop, Riccardo Moia, Chiara Favini, Elisa Spaccarotella, Lorenzo De Paoli, Alessio Bruscaggin, Valeria Spina, Lodovico Terzi-di-Bergamo, Francesca Arruga, Chiara Tarantelli, Clara Deambrogi, Silvia Rasi, Ramesh Adhinaveni, Andrea Patriarca, Simone Favini, Sruthi Sagiraju, Clive Jabangwe, Ahad A. Kodipad, Denise Peroni, Francesca R. Mauro, Ilaria Del Giudice, Francesco Forconi, Agostino Cortel
Published in: Haematologica, Issue 105/2, 2020, Page(s) 448-456, ISSN 0390-6078
Publisher: Ferrata Storti Foundation
DOI: 10.3324/haematol.2019.219550

Genetic and phenotypic attributes of splenic marginal zone lymphoma

Author(s): Bonfiglio F, Bruscaggin A, Guidetti F, Terzi di Bergamo L, Faderl M, Spina V, Condoluci A, Bonomini L, Forestieri G, Koch R, Piffaretti D, Pini K, Pirosa MC, Cittone MG, Arribas A, Lucioni M, Ghilardi G, Wu W, Arcaini L, Baptista MJ, Bastidas G, Bea S, Boldorini R, Broccoli A, Buehler MM, Canzonieri V, Cascione L, Ceriani L, Cogliatti S, Corradini P, Derenzini E, Devizzi L, Dietrich S, Elia AR, Fa
Published in: Blood, 2021, ISSN 0006-4971
Publisher: American Society of Hematology
DOI: 10.1182/blood.2021012386

Ibrutinib dose intensity in high-risk chronic lymphocytic leukemia.

Author(s): Forestieri G, Terzi di Bergamo L, Deodato M, Frustaci AM, Moia R, Deambrogi C, Rasi S, Autore F, Merli M, Mattarucchi R, Fahrni G, Scarfo' L, Gussetti D, Bulian P, Zanatta A, Spina V, Bruscaggin A, Pini K, Piffaretti D, Pirosa MC, Salehi M, Marques de Almeida J, Passweg J, Cavalli F, Zucca E, Gerber B, Stussi G, Gattei V, Ghia P, Gregor M, Passamonti F, Laurenti L, Gaidano G, Tedeschi A, Rossi D,
Published in: Hematological Oncology, 2022, ISSN 0278-0232
Publisher: John Wiley & Sons Inc.
DOI: 10.1002/hon.3032

Lymphocyte doubling time in chronic lymphocytic leukemia modern era: a real-life study in 848 unselected patients

Author(s): Tycho Baumann, Riccardo Moia, Gianluca Gaidano, Julio Delgado, Adalgisa Condoluci, Neus Villamor, Anil Babu Payedimarri, Dolors Costa, Andrea Patriarca, Carlos Jiménez-Vicente, Davide Rossi, Emili Montserrat
Published in: Leukemia, 2021, ISSN 0887-6924
Publisher: Nature Publishing Group
DOI: 10.1038/s41375-021-01149-w

Anatomical heterogeneity of residual disease in chronic lymphocytic leukemia treated with ibrutinib

Author(s): Condoluci A, Milan L, Forestieri G, Terzi di Bergamo L, Spina V, Bruscaggin A, Deambrogi C, Moia R, Deodato M, Fahrni G, Mattarucchi R, Merli M, Gerber B, Stussi G, Passamonti F, Gregor M, Tedeschi A, Gaidano G, Rossi D, Ceriani L.
Published in: Hematological Oncology, 2022, ISSN 0278-0232
Publisher: John Wiley & Sons Inc.
DOI: 10.1002/hon.3039

Circulating tumor DNA for comprehensive noninvasive monitoring of lymphoma treated with ibrutinib plus nivolumab.

Author(s): Bruscaggin A, di Bergamo LT, Spina V, Hodkinson B, Forestieri G, Bonfiglio F, Condoluci A, Wu W, Pirosa MC, Faderl MR, Koch R, Schaffer M, Alvarez JD, Fourneau N, Gerber B, Stussi G, Zucca E, Balasubramanian S, Rossi D.
Published in: Blood Advances, 2021, ISSN 2473-9529
Publisher: American Society of Hematology
DOI: 10.1182/bloodadvances.2021004528

CD49d promotes disease progression in chronic lymphocytic leukemia: new insights from CD49d bimodal expression

Author(s): Erika Tissino, Federico Pozzo, Dania Benedetti, Chiara Caldana, Tamara Bittolo, Francesca Maria Rossi, Riccardo Bomben, Paola Nanni, Hillarj Chivilò, Ilaria Cattarossi, Eva Zaina, Kevin Norris, Jerry Polesel, Massimo Gentile, Giovanni Tripepi, Riccardo Moia, Enrico Santinelli, Idanna Innocenti, Jacopo Olivieri, Giovanni D’Arena, Luca Laurenti, Francesco Zaja, Gabriele Pozzato, Annalisa Chiarenz
Published in: Blood, Issue 135/15, 2020, Page(s) 1244-1254, ISSN 0006-4971
Publisher: American Society of Hematology
DOI: 10.1182/blood.2019003179